Anti-Chk1 抗体 [EP691Y]
Anti-Chk1 antibody [EP691Y]
- 20ul selling size
- RabMAb
- Recombinant
- 詳細を見る
5
(6 Reviews)
|
(46 Publications)
Rabbit Recombinant Monoclonal CHK1 antibody. Suitable for IHC-P, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 46 publications.
別名を表示する
CHK1, CHEK1, Serine/threonine-protein kinase Chk1, CHK1 checkpoint homolog, Cell cycle checkpoint kinase, Checkpoint kinase-1
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Chk1 antibody [EP691Y] (AB40866)
Immunohistochemical analysis of Chk1 expression in paraffin-embedded human breast carcinoma using ab40866 at a 1 : 250 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Chk1 antibody [EP691Y] (AB40866)
Immunofluorescence staining of MCF7 cells with purified ab40866 at a working dilution of 1/500, counter-stained with DAPI. The secondary antibody was an Alexa Fluor® 488 conjugated goat anti-rabbit (ab150077), used at a dilution of 1/1000. The cells were fixed in 4% PFA and permeabilized using 0.1% Triton X 100. The negative control is shown in bottom right hand panel - for the negative control, PBS was used instead of the primary antibody.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Chk1 antibody [EP691Y] (AB40866)
Overlay histogram showing HeLa cells stained with ab40866 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab40866, 1/1000 dilution) for 30 min at 22°C. The secondary antibody used was Alexa Fluor® 488 goat anti-rabbit IgG (H&L) (ab150077) at 1/2000 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (0.1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter.
- WB
Supplier Data
Western blot - Anti-Chk1 antibody [EP691Y] (AB40866)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
UV-C treatment induces phosphorylation of Chk1 at Ser345 (PMID : 20609246).
The identity of the bands higher than 150 kDa are unknown.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
In Western blot, Anti-Chk1 antibody [EP691Y] (ab40866) staining at 56KDa dilution.
All lanes:
Western blot - Anti-Chk1 (phospho S345) antibody [EPR30270-566] (<a href='/products/primary-antibodies/chk1-phospho-s345-antibody-epr30270-566-ab325675'>ab325675</a>) at 1/1000 dilution
Lane 1:
Untreated Synchronized G1/S HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate (untreated membrane) at 20 µg
Lane 2:
Synchronized G1/S HeLa treated with 100 J/m2 UV-C, then recovery for 1 hour whole cell lysate (untreated membrane) at 20 µg
Lane 3:
Untreated Synchronized G1/S HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate (phosphatase treated membrane) at 20 µg
Lane 4:
Synchronized G1/S HeLa treated with 100 J/m2 UV-C, then recovery for 1 hour whole cell lysate (phosphatase treated membrane) at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 56 kDa,36 kDa
false
Exposure time: 180s
- WB
Lab
Western blot - Anti-Chk1 antibody [EP691Y] (AB40866)
Anti-CHEK1 antibody [EP691Y] (ab40866) staining at 1/10000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab40866 was shown to bind specifically to CHEK1. A band was observed at 57 kDa in wild-type A549 cell lysates with a reduction in signal observed at this size in CHEK1 heterozygous knockout cell line. To generate this image, wild-type and CHEK1 heterozygous knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-Chk1 antibody [EP691Y] (ab40866) at 1/10000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
Western blot - Human CHEK1 heterozygous knockout A549 cell line (<a href='/products/cell-lines/human-chek1-heterozygous-knockout-a549-cell-line-ab276102'>ab276102</a>)
Lane 2:
CHEK1 knockout A549 cell lysate at 20 µg
Lane 3:
A431 cell lysate at 20 µg
Lane 4:
MOLT-4 cell lysate at 20 µg
Secondary
Lanes 1 - 4:
Goat anti-Rabbit IgG H&L 800CW at 1/20000 dilution
Lanes 1 - 4:
Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Predicted band size: 54 kDa
Observed band size: 57 kDa
false
- WB
Unknown
Western blot - Anti-Chk1 antibody [EP691Y] (AB40866)
All lanes:
Western blot - Anti-Chk1 antibody [EP691Y] (ab40866) at 1/10000 dilution
All lanes:
HeLa cell lysate at 10 µg
Predicted band size: 54 kDa
Observed band size: 54 kDa
false
関連する標識済み抗体及び組成の異なる製品 (9)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Chk1 antibody [EP691Y]
-
Anti-Chk1 antibody [EP691Y] - BSA and Azide free
-
578 PE
PE Anti-Chk1 antibody [EP691Y]
-
660 APC
APC Anti-Chk1 antibody [EP691Y]
-
HRP Anti-Chk1 antibody [EP691Y]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Chk1 antibody [EP691Y]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-Chk1 antibody [EP691Y]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Chk1 antibody [EP691Y]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-Chk1 antibody [EP691Y]
Reactivity data
製品の詳細
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (46)
Recent publications for all applications. Explore the full list and refine your search
Molecular therapy. Oncology 33:201028 PubMed40896366
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:7064 PubMed40750587
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature 642:785-795 PubMed40399682
2025
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 11:eadu3956 PubMed40238864
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular & cellular oncology 12:2488537 PubMed40226818
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell international 25:100 PubMed40098146
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell biology and toxicology 41:30 PubMed39808342
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular gastroenterology and hepatology 19:101422 PubMed39419394
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 27:109978 PubMed39021796
2024
Applications
Unspecified application
Species
Unspecified reactive species
Translational oncology 41:101858 PubMed38242006
2024
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com